[1]王 韵,彭代辉.迷走神经刺激治疗难治性抑郁研究进展[J].陕西医学杂志,2025,54(4):575-封3.[doi:DOI:10.3969/j.issn.1000-7377.2025.04.028]
 WANG Yun,PENG Daihui.Research Progress on Vagus Nerve Stimulation Therapy for Refractory Depression[J].,2025,54(4):575-封3.[doi:DOI:10.3969/j.issn.1000-7377.2025.04.028]
点击复制

迷走神经刺激治疗难治性抑郁研究进展
分享到:

《陕西医学杂志》[ISSN:1000-7377/CN:61-1281/TN]

卷:
54
期数:
2025年4期
页码:
575-封3
栏目:
综 述
出版日期:
2025-04-05

文章信息/Info

Title:
Research Progress on Vagus Nerve Stimulation Therapy for Refractory Depression
作者:
王 韵彭代辉
(上海市精神卫生中心心境障碍科,上海 200060)
Author(s):
WANG YunPENG Daihui
(Department of Mood Disorders,Shanghai Mental Health Center,Shanghai 200060,China)
关键词:
难治性抑郁症 迷走神经刺激 神经调节 疗效
Keywords:
Treatment refractory depression Vagus nerve stimulation Neural regulation Therapeutic effect
分类号:
R 749.42
DOI:
DOI:10.3969/j.issn.1000-7377.2025.04.028
文献标志码:
A
摘要:
难治性抑郁症(TRD)是一种难以治疗的抑郁症类型,通常对抗抑郁药物和心理治疗无效。近年来,迷走神经刺激(VNS)作为一种新的神经调节技术逐渐成为治疗TRD的一种备选方案。本文通过系统综述现有文献探讨迷走神经刺激在TRD治疗中的应用现状、机制及其疗效,并分析其临床局限性与未来研究方向。
Abstract:
Treatment Refractory Depression(TRD)is a type of depression that is difficult to treat and often ineffective with antidepressants and psychotherapy.In recent years,vagus nerve stimulation(VNS)has gradually become an alternative treatment for TRD as a new neuroregulatory technique.This article systematically reviews existing literature to explore the current application status,mechanism,and efficacy of vagus nerve stimulation in the treatment of TRD,and analyzes its clinical limitations and future research directions.

参考文献/References:

[1] 范瑞娟,朱世杰,唐中生,等.基于TLR4/MyD88信号通路探讨经皮耳迷走神经刺激对血管性痴呆大鼠学习记忆的影响 [J].贵州中医药大学学报,2024,46(5):34-38.
[2] 何宇,WINTER Y.迷走神经刺激治疗嗜睡症 [J].中国康复,2024,39(9):529.
[3] 任红贤,辛志俊,季文赛,等.经皮耳迷走神经刺激治疗腰椎间盘突出症的临床疗效 [J].武警医学,2024,35(9):740-744.
[4] 刘显阳,李琨,张小刚,等.重复经颅磁刺激对冠心病并发焦虑的影响研究[J].陕西医学杂志,2016,45(1):37-38.
[5] 李大雷,赵灿伟.针刺治疗脑卒中后抑郁疗效研究[J].陕西中医,2020,41(10):1489-1491..
[6] 刘娟,田磊,赵杨,等.电针对慢性应激抑郁模型大鼠脑组织内大麻素水解酶的影响[J].陕西中医,2019,40(5):553-555.
[7] 景致英,行气活血方合针刺组穴治疗难治性抑郁症疗效观察[J].陕西中医,2013,34(8):1007-1008.
[8] 赵晶,乔海法.耳迷走神经刺激改善妊娠高血压大鼠胎盘滋养层细胞线粒体功能障碍的作用机制研究 [J].医用生物力学,2024,39(S1):268.
[9] 王玫懿.倍他司汀和经皮迷走神经刺激联合治疗对梅尼埃病的疗效 [J].中国康复,2024,39(7):410.
[10] 王彩贞,苗丽娜,陈源,等.高频迷走神经刺激治疗难治性癫痫有效性的Meta分析 [J].临床荟萃,2024,39(7):593-597.
[11] 马跃.经皮耳穴迷走神经刺激治疗抑郁症的脑肠机制初步探索研究[D].北京:中国中医科学院,2024.
[12] 毛宏亮.迷走神经刺激治疗药物难治性癫痫的疗效、安全性及预后因素分析[D].合肥:安徽医科大学,2024.
[13] 郭阳.经皮耳迷走神经刺激促进抑郁大学生奖赏动机研究[D].合肥:安徽医科大学,2024.
[14] 崔雨秋.经皮耳迷走神经刺激干预抑郁大学生反应抑制能力的研究[D].合肥:安徽医科大学,2024.
[15] 王梦寰,孔雨柔,谢敏,等.经皮迷走神经刺激联合任务导向训练改善卒中后偏瘫患者上肢功能的研究 [J].中国康复医学杂志,2024,39(6):782-790.
[16] 简荣荣,谢磊,曹孟德.循经点穴推拿联合经皮耳迷走神经刺激治疗产后功能性消化不良临床研究 [J].新中医,2024,56(11):135-140.
[17] 潘远航.经皮耳甲迷走神经刺激治疗1型发作性睡病的临床研究[D].西安:中国人民解放军空军军医大学,2024.
[18] 张欣,贾功伟,虞乐华,等.迷走神经刺激对急性呼吸窘迫综合征大鼠Th17和Treg相关蛋白及炎症因子的影响 [J].海军军医大学学报,2024,45(5):544-551.
[19] EDITORIAL A.Systematic review of depression[J].Current Neuropharmacology,2023,13(4):480.
[20] KESSLER R C,ANGERMEYER M,ANTHONY J C,et al.Lifetime prevalence and ageof-onset distributions of mental disorders in the World Health Organization's World Mental Health Survey Initiative[J].World Psychiatry:Official Journal of the World Psychiatric Association(WPA),2021,6(3):168-176.
[21] COVID-19 MENTAL DISORDERS COLLABORATORS.Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic[J].Lancet(London,England),2021,398(10312):1700-1712.
[22] THAPAR A,EYRE O,PATEL V,et al.Depression in young people[J].Lancet(London,England),2022,400(10352):617-631.
[23] BERTHA E A,BALÁZS J.Subthreshold depression in adolescence:A systematic review[J].European Child & Adolescent Psychiatry,2023,22(10):589-603.
[24] FLETT G L,VREDENBURG K,KRAMES L.The continuity of depression in clinical and nonclinical samples[J].Psychological Bulletin,2022,121(3):395-416.
[25] ANGST J,MERIKANGAS K.The depressive spectrum:diagnostic classification and course[J].Journal of Affective Disorders,2021,45(1-2):31-40.
[26] CUIJPERS P,DE GRAAF R,VAN DORSSELAER S.Minor depression:Risk profiles,functional disability,health care use and risk of developing major depression[J].Journal of Affective Disorders,2024,79(1):71-79.
[27] LEWINSOHN P M,SOLOMON A,SEELEY J R,et al.Clinical implications of “subthreshold” depressive symptoms[J].Journal of Abnormal Psychology,2021,109(2):345-351.
[28] EATON W W,BADAWI M,MELTON B.Prodromes and precursors:Epidemiologic data for primary prevention of disorders with slow onset[J].The American Journal of Psychiatry,2022,152(7):967-972.
[29] MIKOLAJCZYK R T,MAXWELL A E,ELANSARI W,et al.Prevalence of depressive symptoms in university students from Germany,Denmark,Poland and Bulgaria[J].Social Psychiatry and Psychiatric Epidemiology,2021,43(2):105-112.
[30] PIZZAGALLI D A.Toward a better understanding of the mechanisms and pathophysiology of anhedonia:Are we ready for translation?[J].American Journal of Psychiatry,2022,179(7):458-469.
[31] MC MAKIN D L,OLINO T M,PORTA G,et al.Anhedonia predicts poorer recovery among youth with selective serotonin reuptake inhibitor treatment-resistant depression[J].Journal of the American Academy of Child and Adolescent Psychiatry,2022,51(4):404-411.
[32] DOWNAR J,GERACI J,SALOMONS T V,et al.Anhedonia and reward-circuit connectivity distinguish nonresponders from responders to dorsomedial prefrontal repetitive transcranial magnetic stimulation in major depression[J].Biological Psychiatry,2023,76(3):176-185.
[33] TREADWAY M T,ZALD D H.Reconsidering anhedonia in depression:Lessons from translational neuroscience[J].Neuroscience and Biobehavioral Reviews,2021,35(3):537-555.
[34] STRAUSS G P,HONG L E,GOLD J M,et al.Factor structure of the Brief Negative Symptom Scale[J].Schizophrenia Research,2022,142(1-3):96-98.
[35] SLANEY C,PERKINS A M,DAVIS R,et al.Objective measures of reward sensitivity and motivation in people with high v.low anhedonia[J].Psychological Medicine,2022:1-9.
[36] RIZVI S J,PIZZAGALLI D A,SPROULE B A,et al.Assessing anhedonia in depression:Potentials and pitfalls[J].Neuroscience and Biobehavioral Reviews,2023,65:21-35.

备注/Memo

备注/Memo:
[基金项目]上海市精神卫生中心“卓越教师培养计划”(2023-ZY-04); 上海交通大学“交大之星”计划医工交叉研究基金资助项目(YG2022QN107)
更新日期/Last Update: 2025-04-07